Cytomegalovirus DNA polymerase activity and an 80 kDa-associated polypeptide: a potential diagnostic tool for CMV disease

• Published in: Journal of virological methods Vol. 46; no. 2; p. 207
• Main Authors: Hassan, M I, Nokta, M A, Pollard, R B
• Format: Journal Article
• Language: English
• Published: Netherlands 01-02-1994
• Subjects: Cells, Cultured; Cytomegalovirus - enzymology; Cytomegalovirus Infections - enzymology; Cytomegalovirus Infections - microbiology; Cytomegalovirus Infections - urine; Cytomegalovirus Retinitis - enzymology; Cytomegalovirus Retinitis - microbiology; Cytomegalovirus Retinitis - urine; DNA-Directed DNA Polymerase - chemistry; DNA-Directed DNA Polymerase - isolation & purification; DNA-Directed DNA Polymerase - metabolism; Fibroblasts; Humans; Immunoblotting
• ISSN: 0166-0934
• DOI: 10.1016/0166-0934(94)90104-X

CMV has been reported to be associated with a DNA polymerase activity (DPA). In this communication its purification, characterization and potential diagnostic value were examined. CMV DNA polymerase was prepared from cell free supernatants of CMV (AD 169) infected cultures. Separation and purification of the enzyme was accomplished by column chromatography of the purified, lysed virus. CMV DPA was measured on an oligo (dT)-poly (dA) template primer. SDS-PAGE and western blot analysis under reducing conditions using an anti-CMV early antibody showed an 80 kDa protein band that was associated with the peak of polymerase activity. However, CMV isolates and CMV from urines from CMV retinitis patients immunoblotted by the same Ab revealed 140 kDa and 80 kDa bands under non-reducing and reducing conditions respectively, the latter was also associated with a 58 kDa band. The diagnostic value of the CMV associated DAP was tested using CMV positive urines. The latter demonstrated high PAA-sensitive DPA activity, compared to normal, HSV positive urines and urines from HBSAg positive patients. Taken collectively, these findings indicate the potential usefulness of CMV-associated DNA polymerase activity in the diagnosis and follow-up of patients with CMV-related illnesses.